Clinical Trial Update: Comparing Alkalinizing Agents Efficacy on Stone Risk in Patients on a Metabolically Controlled Diet [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 study comparing alkalinizing agents for reducing nephrolithiasis risk in patients on a metabolically controlled diet; recruitment has not yet b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nephrolithiasis

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Kidney Stone | EARLY_Phase 1 | Status: NOT_YET_RECRUITING